| 000 | 01268 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515093511.0 | ||
| 264 | 0 | _c20071227 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a0214-0934 | ||
| 024 | 7 |
_a10.1358/dnp.2007.20.7.1149632 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoros, Eliza | |
| 245 | 0 | 0 |
_aThe role of glycogen synthase kinase-3beta in schizophrenia. _h[electronic resource] |
| 260 |
_bDrug news & perspectives _cSep 2007 |
||
| 300 |
_a437-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xmetabolism |
| 650 | 0 | 4 |
_aDrug Therapy _xtrends |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xadverse effects |
| 650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 | _aReelin Protein |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aDorner-Ciossek, Cornelia | |
| 773 | 0 |
_tDrug news & perspectives _gvol. 20 _gno. 7 _gp. 437-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/dnp.2007.20.7.1149632 _zAvailable from publisher's website |
| 999 |
_c17509818 _d17509818 |
||